Published in Cancer Weekly, December 8th, 2009
You can SIGN UP NOW http://Signup.QualityStocks.net Denis Corin, President of TapImmune, has the company focused on developing innovative therapeutics and vaccines in the areas of oncology and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.